Related Experiment Video
Updated: Jun 13, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal drug exposure: infant and toddler outcomes
Emmalee S Bandstra1, Connie E Morrow, Elana Mansoor
1University of Miami Miller School of Medicine, Department of Pediatrics, Division of Neonatal Medicine, Miami, FL 33101, USA. ebandstr@med.miami.edu
Insights
Maternal opioid and cocaine use during pregnancy can impact infant development. While opioids may cause neonatal abstinence syndrome, cocaine exposure is linked to subtle neurodevelopmental deficits, with long-term effects still under investigation.
Area of Science:
- Obstetrics and Gynecology
- Pediatrics
- Neonatology
- Developmental Psychology
Background:
- Maternal drug use during pregnancy, particularly opioids and cocaine, presents significant risks to infant and toddler development.
- Opioid use includes heroin and treatments like methadone and buprenorphine, while cocaine use encompasses crack cocaine.
- Previous research on prenatal cocaine exposure led to concerns about severe developmental issues, often termed 'crack baby' syndrome.
Purpose of the Study:
- To review the scientific literature on the effects of maternal opioid and cocaine use on infant and toddler outcomes from birth to age three.
- To highlight findings from controlled studies comparing different opioid treatments and cocaine exposure effects.
- To discuss the diagnosis and management of neonatal abstinence syndrome.
Main Methods:
- Systematic review of current scientific literature.
- Analysis of prospective studies comparing drug-exposed and non-exposed infants and toddlers.
- Focus on outcomes including anthropometric growth, neurobehavior, sensory function, and cognitive, motor, and language development.
Main Results:
- Opioid exposure, including methadone and buprenorphine, can lead to neonatal abstinence syndrome and neurobehavioral deficits.
- Prenatal cocaine exposure is associated with statistically significant but subtle decrements in neurobehavioral, cognitive, and language function.
- The impact of cocaine exposure may be moderated by other exposures and the caregiving environment, with less severe outcomes than initially feared.
Conclusions:
- Prenatal opioid exposure requires careful management of neonatal abstinence syndrome and monitoring for neurobehavioral deficits.
- Prenatal cocaine exposure may result in subtle developmental differences, necessitating further longitudinal research to understand long-term impacts.
- The caregiving environment plays a crucial role in mediating developmental outcomes for infants exposed to drugs in utero.
Abstract:
This manuscript provides an overview of the current scientific literature on the impact of maternal drug use, specifically opioids and cocaine, during pregnancy on the acute and long-term outcomes of infants and toddlers from birth through age 3 years. Emphasis with regard to opioids is placed on heroin and opioid substitutes used to treat opioid addiction, including methadone, which has long been regarded as the standard of care in pregnancy, and buprenorphine, which is increasingly being investigated and prescribed as an alternative to methadone. Controlled studies comparing methadone at high and low doses, as well as those comparing methadone with buprenorphine, are highlighted and the diagnosis and management of neonatal abstinence syndrome is discussed. Over the past two decades, attention of the scientific and lay communities has also been focused on the potential adverse effects of cocaine and crack cocaine, especially during the height of the cocaine epidemic in the United States. Herein, the findings are summarized from prospective studies comparing cocaine-exposed with non-cocaine-exposed infants and toddlers with respect to anthropometric growth, infant neurobehavior, visual and auditory function, and cognitive, motor, and language development. The potentially stigmatizing label of the so-called "crack baby" preceded the evidence now accumulating from well-designed prospective investigations that have revealed less severe sequelae in the majority of prenatally exposed infants than originally anticipated. In contrast to opioids, which may produce neonatal abstinence syndrome and infant neurobehavioral deficits, prenatal cocaine exposure appears to be associated with what has been described as statistically significant but subtle decrements in neurobehavioral, cognitive, and language function, especially when viewed in the context of other exposures and the caregiving environment which may mediate or moderate the effects. Whether these early findings may herald more significant learning and behavioral problems during school-age and adolescence when the child is inevitably confronted with increasing social and academic challenges is the subject of ongoing longitudinal research.
More Related Videos
Related Concept Videos
Factors Affecting Drug Response: Overview
Drug Dosing: Infants and Children
Teratogenicity
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Toxicity: Risk factors

